A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813 Conference

Bell, EH, McElroy, JP, Fleming, J et al. (2016). A Mutation and Prognostic Biomarker Study in Grade II and III Gliomas Utilizing a Combined Cohort of NRG Oncology/RTOG 9802 and 9813 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 96(2), S91-S91. 10.1016/j.ijrobp.2016.06.229

Open Access International Collaboration

cited authors

  • Bell, EH; McElroy, JP; Fleming, J; Timmers, C; Chakraborty, AR; Salavaggione, AL; Chang, SM; Shaw, EG; Aldape, K; Brachman, D; Schultz, CJ; Shih, HA; Curtis, M; Hunter, GK; Murtha, AD; Zhang, P; Won, M; Mehta, MP; Chakravarti, A

authors

date/time interval

  • September 25, 2016 -

publication date

  • October 1, 2016

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • Boston, MA

Digital Object Identifier (DOI)

Conference

  • 58th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S91

end page

  • S91

volume

  • 96

issue

  • 2